Your browser doesn't support javascript.
loading
Docetaxel (Taxotere) as monotherapy in the treatment of hormone-refractory prostate cancer: preliminary results.
Picus, J; Schultz, M.
Affiliation
  • Picus J; Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA.
Semin Oncol ; 26(5 Suppl 17): 14-8, 1999 Oct.
Article in En | MEDLINE | ID: mdl-10604263
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Paclitaxel / Antineoplastic Agents, Hormonal / Taxoids / Neoplasms, Hormone-Dependent / Antineoplastic Agents, Phytogenic Limits: Aged / Humans / Male / Middle aged Language: En Journal: Semin Oncol Year: 1999 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Paclitaxel / Antineoplastic Agents, Hormonal / Taxoids / Neoplasms, Hormone-Dependent / Antineoplastic Agents, Phytogenic Limits: Aged / Humans / Male / Middle aged Language: En Journal: Semin Oncol Year: 1999 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos